Finasteride is not dangerous for most people who take it, but it does carry real risks that deserve a clear-eyed look. At the standard 1 mg daily dose used for hair loss, roughly 5% of men experience at least one sexual side effect, compared to about 3% on a placebo. That gap is smaller than many people expect, but the nature of those side effects, and questions about how long they last, make this a drug worth understanding before you start.
How Finasteride Works in Your Body
Finasteride blocks an enzyme that converts testosterone into a more potent hormone called DHT. DHT is the primary driver of male pattern hair loss, but it also plays roles in prostate health, sexual function, and other tissues. A 1 mg daily dose reduces DHT levels in the scalp by over 90% and in the bloodstream by up to 70%. That dramatic reduction is what makes the drug effective for hair loss, but it’s also why side effects can touch several body systems at once.
Sexual Side Effects: What the Numbers Show
Sexual side effects are the concern most people have heard about, and they’re the most studied. A systematic review pooling data from clinical trials found that 5.3% of men taking 1 mg finasteride daily reported at least one sexual side effect, versus 3.05% on placebo. That means the drug itself is responsible for side effects in roughly 2 out of every 100 users beyond what you’d see from taking a sugar pill.
Breaking that down further, the clearest signal is for erectile dysfunction, where finasteride nearly doubled the risk compared to placebo. Decreased libido and difficulty with ejaculation also trended higher, though those increases didn’t reach statistical significance in pooled analyses. A large 2017 study of over 3,100 men reported an even lower side effect rate of 0.7%, and a separate review of more than 17,000 patients found that men taking finasteride specifically for hair loss (rather than for prostate conditions at higher doses) showed no statistically significant increase in sexual problems.
The picture, in other words, is mixed. Side effects are real but affect a minority of users, and trial results vary depending on how they’re designed and who’s enrolled.
Do Side Effects Go Away if You Stop?
For most men, yes. Sexual side effects typically resolve after discontinuing the drug. But this is the part of the story that generates the most anxiety: not everyone recovers quickly, and some report that problems persist. The UK’s medicines regulator noted that in almost half of the adverse event reports it reviewed, the outcome was recorded as “not recovered” or “not resolved.” That’s a striking number, though it comes with an important caveat. Adverse event databases capture the worst outcomes disproportionately, because people who recover fully are less likely to file a report.
Still, the possibility of lasting effects is taken seriously enough that regulators in both the US and UK have updated finasteride’s prescribing information to warn that sexual dysfunction, including reduced libido and erectile dysfunction, may persist after stopping treatment.
Post-Finasteride Syndrome
A small number of former users report a cluster of symptoms that continues months or years after quitting the drug. This has been labeled post-finasteride syndrome, or PFS, and it includes sexual symptoms like erectile dysfunction, low libido, and genital numbness alongside psychiatric symptoms such as depression, anxiety, brain fog, insomnia, and in some cases suicidal thoughts.
PFS is considered rare, and there are no established diagnostic criteria or a confirmed biological mechanism explaining it. That doesn’t mean people aren’t experiencing real symptoms. It means the medical community hasn’t yet been able to measure how common it is, predict who’s at risk, or develop a reliable treatment. For now, PFS remains a recognized but poorly understood condition that primarily affects younger men.
Mental Health Concerns
In 2022, the FDA updated Propecia’s label to include depression and suicidal ideation in the postmarketing side effects section. This was based on voluntary reports from patients and doctors after the drug reached the market, not from controlled trials, so the exact rate is unknown. What is known is that the signal was strong enough for the FDA to act on it.
If you have a history of depression or anxiety, this is worth discussing before starting finasteride. The psychiatric side effects reported by PFS patients, including panic attacks, feelings of disconnection, and cognitive changes, overlap heavily with mood disorders, which can make them difficult to attribute to the drug with certainty on an individual level.
Breast Tissue Changes
Because finasteride shifts the balance between testosterone and estrogen by lowering DHT, some men develop breast tenderness or enlargement (gynecomastia). At the higher 5 mg dose used for prostate conditions, a large meta-analysis found gynecomastia in about 3.3% of users versus 1.8% on placebo. At the 1 mg hair loss dose, this side effect is rarely reported, and no large-scale study has measured its exact rate. In isolated case reports, breast tissue changes have persisted even after stopping the drug.
Effects on Fertility
Some men taking finasteride have had semen analyses showing reduced sperm quality or count. The NHS notes this is not a common side effect, and sperm parameters typically return to normal after stopping the medication. If you’re actively trying to conceive, it’s worth knowing that finasteride can potentially interfere, but the effect appears reversible for most men.
The Prostate Cancer Question
The Prostate Cancer Prevention Trial, one of the largest studies ever conducted on finasteride, found that the drug reduced overall prostate cancer risk by about 25%. However, it also found a higher proportion of aggressive, high-grade tumors among men who did develop cancer while on finasteride. That finding alarmed researchers initially, but closer analysis tempered the concern. When tumors were examined after surgical removal rather than just biopsy, the difference in high-grade cancer rates between finasteride and placebo groups shrank substantially and was no longer statistically significant. The current interpretation is that finasteride likely makes existing high-grade cancers easier to detect on biopsy rather than causing them, though the debate continued for years.
Putting the Risk in Perspective
Finasteride at 1 mg daily is one of the most effective treatments for male pattern hair loss, and the majority of men who take it experience no notable side effects. The risks that do exist are concentrated in a few areas: a modest increase in sexual side effects that usually resolves after stopping, a small but real possibility of persistent symptoms, and a less-defined risk of mood changes. The drug has been prescribed to millions of men over three decades, and serious adverse outcomes remain uncommon.
What makes finasteride a difficult decision isn’t the size of the risk. It’s the nature of it. The side effects that worry people most, lasting sexual dysfunction and depression, are the hardest to predict, the hardest to measure, and the hardest to reverse if they occur. For many men, the low probability makes finasteride a reasonable choice. For others, particularly those with pre-existing mood disorders or strong concerns about sexual health, the uncertainty alone may tip the balance.